Your browser doesn't support javascript.
loading
Efficacy and safety of evogliptin versus sitagliptin as an add-on therapy in Indian patients with type 2 diabetes mellitus inadequately controlled with metformin: A 24-week randomized, double-blind, non-inferiority, EVOLUTION INDIA study.
Ajmani, Ajay Kumar; Agrawal, Aparna; Prasad, B L N; Basu, Indraneel; Shembalkar, Jayashree; Manikanth, Neeraj; Subrahmanyam, K A V; Srinivasa, M; Chawla, Manoj; Srivastava, Manoj Kumar; Jebasingh, Felix; Achappa, Basavaprabhu; Agrawal, R P; Pulichikkat, Rakesh K; Meena, Ramdhan; Bhatia, Shailaja; Gupta, Sandeep Kumar; Dange, Amol; Srivastava, Ambrish; Trailokya, Abhijit; Shahavi, Vinayaka; Shende, Sachin.
Afiliação
  • Ajmani AK; Dr. B. L. Kapur Super Speciality Hospital, New Delhi, India.
  • Agrawal A; Lady Hardinge Medical College & Smt. Sucheta Kriplani Hospital, New Delhi, India.
  • Prasad BLN; Rajiv Gandhi Institute of Medical Sciences and RIMS Government General Hospital, Srikakulam, India.
  • Basu I; Popular Hospital, Varanasi, India.
  • Shembalkar J; Getwell Hospital and Research Institute, Nagpur, India.
  • Manikanth N; Government Medical College, Kerala, India.
  • Subrahmanyam KAV; Andhra Medical College, King George Hospital, Vishakhapatnam, India.
  • Srinivasa M; Krishna Rajendra Hospital, Mysore Medical College & Research Institute, Mysore, India.
  • Chawla M; BSES Municipal General Hospital, Mumbai, India.
  • Srivastava MK; Om Surgical Center & Maternity Home, Varanasi, India.
  • Jebasingh F; Christian Medical College, Vellore, India.
  • Achappa B; Kasturba Medical College, Mangalore, India.
  • Agrawal RP; SP Medical College and PBM Hospital, Bikaner, India.
  • Pulichikkat RK; Sree Narayana Institute of Medical Sciences, Kochi, India.
  • Meena R; S.R. Kalla Memorial Gastro and General Hospital, Jaipur, India.
  • Bhatia S; Medipoint Hospitals Pvt Ltd, Pune, India.
  • Gupta SK; KRM Hospital and Research Centre, Lucknow, India.
  • Dange A; Lifepoint Multispecialty Hospital, Pune, India.
  • Srivastava A; Alkem Laboratories Ltd, Mumbai, India.
  • Trailokya A; Alkem Laboratories Ltd, Mumbai, India. Electronic address: publication@alkem.com.
  • Shahavi V; Alkem Laboratories Ltd, Mumbai, India.
  • Shende S; Alkem Laboratories Ltd, Mumbai, India.
Diabetes Res Clin Pract ; 157: 107860, 2019 Nov.
Article em En | MEDLINE | ID: mdl-31526825
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Fosfato de Sitagliptina / Hipoglicemiantes / Metformina Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Fosfato de Sitagliptina / Hipoglicemiantes / Metformina Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2019 Tipo de documento: Article